NovoCure Limited - Ordinary Shares (NQ:NVCR)

14.80 -0.13 (-0.90%)

Delayed Quote Updated: 10:51 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

Why Novocure Stock Is Flying High ↗

January 06, 2023

Here's why Novocure stock popped over 68% on Jan. 5.

Via The Motley Fool

Why Novocure Stock Is Skyrocketing Today ↗

January 05, 2023

The company announced good news from a late-stage study of its Tumor Treating Fields therapy.

Via The Motley Fool

Novocure Skyrockets After Pulling Off A Once-In-Six-Years Feat ↗

January 05, 2023

The company is now planning to ask for FDA approval in the second half of 2023.

Via Investor's Business Daily

Where NovoCure Stands With Analysts ↗

November 29, 2022

Via Benzinga

Tesla, Amazon, Aehr, Silvergate, Novocure: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

January 05, 2023

Major Wall Street indices closed over 1% lower on Thursday, dragged by strong employment data which could nudge the Federal Reserve to continue its rate hikes.

Via Benzinga

Why Shares of Zai Lab Soared This Week ↗

January 05, 2023

A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.

Via The Motley Fool

Dow Falls Over 200 Points; Walgreens Earnings Top Expectations ↗

January 05, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 200 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 05, 2023

Via Benzinga

Nasdaq Down Over 100 Points; Crude Oil Rises 1% ↗

January 05, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite shedding more than 100 points on Thursday.

Via Benzinga

Why Novocure Stock Is Jumping Today ↗

November 29, 2022

Novocure's innovative cancer therapy picked up a big win in Canada.

Via The Motley Fool

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

Why Is Huadi International (HUDI) Stock Up 30% Today? ↗

January 05, 2023

Huadi International (HUDI) stock is climbing higher on Thursday even without specific news from the Chinese steel company.

Via InvestorPlace

Why Is Magic Empire Global (MEGL) Stock Up 83% Today? ↗

January 05, 2023

Magic Empire Global (MEGL) stock is rocketing higher on Thursday despite a lack of news from the Hong Kong financial services provider.

Via InvestorPlace

NovoCure (NVCR) Stock Soars 50% on Positive Clinical Trial Results ↗

January 05, 2023

NVCR stock traders are undeniably pleased to see NovoCure marking a milestone in the company's quest to treat a specific type of lung cancer.

Via InvestorPlace

Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients ↗

January 05, 2023

Via Benzinga

This Good News on Cancer Sent 2 Nasdaq Stocks Soaring ↗

January 05, 2023

Biotech investors are optimistic about the prospects for a potential treatment.

Via The Motley Fool

US Stocks Open Lower; Dow Tumbles 300 Points ↗

January 05, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 05, 2023

Via Benzinga

Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

January 05, 2023

From Zai Lab Limited

Via GlobeNewswire

Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

January 05, 2023

From Novocure

Via Business Wire

Novocure to Participate in 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

From Novocure

Via Business Wire

3 Stocks That Could Soar in a Santa Claus Rally ↗

December 25, 2022

These stocks are primed for a holiday surge.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

3 Top Stocks to Buy Hand Over Fist Before the End of 2022 ↗

December 12, 2022

You probably shouldn't wait for long to buy these stocks.

Via The Motley Fool

5 Top Stocks for December ↗

December 04, 2022

From game-changing products to indisputable growth catalysts, this list of top stocks has something for all.

Via The Motley Fool

12 Top Stocks to Buy in December ↗

December 03, 2022

Add this dandy dozen to your stocking this month.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 ↗

November 29, 2022

Via Benzinga

Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

November 29, 2022

From Novocure

Via Business Wire

FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday ↗

November 29, 2022

Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.